These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24052459)

  • 1. Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data.
    Fotheringham J; Jacques RM; Fogarty D; Tomson CR; El Nahas M; Campbell MJ
    Nephrol Dial Transplant; 2014 Feb; 29(2):422-30. PubMed ID: 24052459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy.
    Fotheringham J; Fogarty D; Jacques R; El Nahas M; Campbell M
    Nephron Clin Pract; 2012; 120 Suppl 1():c247-60. PubMed ID: 22964571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK Renal Registry 16th annual report: chapter 5 comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2011 to 2012.
    Rao A; Steenkamp R; Caskey F
    Nephron Clin Pract; 2013; 125(1-4):99-110. PubMed ID: 24662169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 4 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2009 to 2010.
    Shaw C; Webb L; Casula A; Tomson CR
    Nephron Clin Pract; 2012; 120 Suppl 1():c81-91. PubMed ID: 22964575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK Renal Registry 11th Annual Report (December 2008): Chapter 6 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland: national and centre-specific analyses.
    Udayaraj U; Tomson CR; Gilg J; Ansell D; Fogarty D
    Nephron Clin Pract; 2009; 111 Suppl 1():c97-111. PubMed ID: 19542707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK Renal Registry 15th annual report: Chapter 5 survival and causes of death of UK adult patients on renal replacement therapy in 2011: national and centre-specific analyses.
    Steenkamp R; Shaw C; Feest T
    Nephron Clin Pract; 2013; 123 Suppl 1():93-123. PubMed ID: 23774488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK Renal Registry 16th annual report: chapter 8 survival and cause of death of UK adult patients on renal replacement therapy in 2012: national and centre-specific analyses.
    Pruthi R; Steenkamp R; Feest T
    Nephron Clin Pract; 2013; 125(1-4):139-69. PubMed ID: 24662172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK Renal Registry 13th Annual Report (December 2010): Chapter 4: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2008 to 2009.
    Webb L; Gilg J; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c85-96. PubMed ID: 21894042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK Renal Registry 12th Annual Report (December 2009): chapter 6: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2003 to 2008: national and centre-specific analyses.
    Caskey F; Webb L; Gilg J; Fogarty D
    Nephron Clin Pract; 2010; 115 Suppl 1():c103-16. PubMed ID: 20413944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK Renal Registry 13th Annual Report (December 2010): Chapter 6: survival and causes of death of UK adult patients on renal replacement therapy in 2009: national and centre-specific analyses.
    Castledine C; Steenkamp R; Feest T; Tomson CR
    Nephron Clin Pract; 2011; 119 Suppl 2():c107-34. PubMed ID: 21894029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons.
    Boddana P; Caskey F; Casula A; Ansell D
    Nephron Clin Pract; 2009; 111 Suppl 1():c269-76. PubMed ID: 19542702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of incident RRT patients in the UK (chapter 12).
    Ansell D; Roderick P; Udayaraj U; van Schalkwyk D; Tomson C
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii155-64. PubMed ID: 17724043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 6 Survival and causes of death of UK adult patients on renal replacement therapy in 2010: national and centre-specific analyses.
    Steenkamp R; Castledine C; Feest T
    Nephron Clin Pract; 2012; 120 Suppl 1():c105-35. PubMed ID: 22964564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns and effects of missing comorbidity data for patients starting renal replacement therapy in England, Wales and Northern Ireland.
    Collier T; Steenkamp R; Tomson C; Caskey F; Ansell D; Roderick P; Nitsch D
    Nephrol Dial Transplant; 2011 Nov; 26(11):3651-8. PubMed ID: 21436380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UK Renal Registry 11th Annual Report (December 2008): Chapter 7 Survival and causes of death of UK adult patients on renal replacement therapy in 2007: national and centre-specific analyses.
    Ansell D; Roderick P; Hodsman A; Ford D; Steenkamp R; Tomson C
    Nephron Clin Pract; 2009; 111 Suppl 1():c113-39. PubMed ID: 19542694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK Renal Registry 12th Annual Report (December 2009): chapter 7: survival and causes of death of UK adult patients on renal replacement therapy in 2008: national and centre-specific analyses.
    Ansell D; Roderick P; Steenkamp R; Tomson CR
    Nephron Clin Pract; 2010; 115 Suppl 1():c117-44. PubMed ID: 20413945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK Renal Registry 11th Annual Report (December 2008): Chapter 3 ESRD incident rates in 2007 in the UK: national and centre-specific analyses.
    Farrington K; Udayaraj U; Gilg J; Feehally J
    Nephron Clin Pract; 2009; 111 Suppl 1():c13-41. PubMed ID: 19542695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
    Storey BC; Staplin N; Harper CH; Haynes R; Winearls CG; Goldacre R; Emberson JR; Goldacre MJ; Baigent C; Landray MJ; Herrington WG
    Kidney Int; 2018 May; 93(5):1165-1174. PubMed ID: 29395337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK Renal Registry 11th Annual Report (December 2008): Chapter 15 The UK Renal Registry, UKRR database, validation and methodology.
    Ansell D; Tomson CR
    Nephron Clin Pract; 2009; 111 Suppl 1():c277-85. PubMed ID: 19542703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK Renal Registry 11th Annual Report (December 2008): Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-specific analyses.
    Farrington K; Hodsman A; Casula A; Ansell D; Feehally J
    Nephron Clin Pract; 2009; 111 Suppl 1():c43-68. PubMed ID: 19542705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.